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To investigate if apparent diffusion coefficient (ADC) values within primary central nervous
system lymphoma correlate with cellularity and proliferative activity in corresponding histo-
logical samples.
Materials and Methods
Echo-planar diffusion-weighted magnetic resonance images obtained from 21 patients with
primary central nervous system lymphoma were reviewed retrospectively. Regions of inter-
est were drawn on ADCmaps corresponding to the contrast enhancing parts of the tumors.
Biopsies from all 21 patients were histologically analyzed. Nuclei count, total nuclei area
and average nuclei area were measured. The proliferation index was estimated as Ki-67
positive nuclei divided by total number of nuclei. Correlations of ADC values and histopatho-
logic parameters were determined statistically.
Results
Ki-67 staining revealed a statistically significant correlation with ADCmin (r = -0.454, p =
0.038), ADCmean (r = -0.546, p = 0.010) and ADCmax (r = -0.515, p = 0.017). Furthermore,
ADCmean correlated in a statistically significant manner with total nucleic area (r = -0.500,
p = 0.021).
Conclusion
Low ADCmin, ADCmean and ADCmax values reflect a high proliferative activity of primary
cental nervous system lymphoma. Low ADCmean values—in concordance with several
previously published studies—indicate an increased cellularity within the tumor.
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Introduction
Primary lymphomas of the central nervous system account for approximately 4% of newly
diagnosed brain tumors[1]. Representing a subgroup of Non-Hodgkin Lymphoma (NHL),
more than 90% of them are classified as Diffuse Large B-Cell Lymphoma (DLBCL). Occurrence
of primary CNS lymphoma (PCNSL) strongly correlates with immunosuppression, either iat-
rogenic, infectious or congenital[2]. Although PCNSL in immunocompromised subjects show
an association with Epstein-Barr Virus (EBV), the incidence rate of PCNSL in immunocompe-
tent subjects without EBV has increased sharply over the last thirty years[3]. PCNSL rarely
extends beyond the CNS. This is postulated to be due to the immune privilege of the CNS[4].
The neoplastic lymphocytes are identified and removed from the immunologically more active
periphery, but persist in the CNS where the immunological surveillance is comparatively less
fine-meshed, enabling them to maintain active proliferation.
In clinical practice, Ki-67 is a widely used cellular marker for proliferative activity in lym-
phoma and other malignancies[5]. The nonhistone nuclear protein is synthesized throughout
the whole cell cycle except the G0 phase, and has been shown to be responsible for cell division
[6]. The prognostic value of Ki-67 in different histopathologic subtypes of lymphoma has been
examined in multiple studies[5]. For example, a high level of Ki-67 expression is associated
with a decreased overall survival but a good therapeutical response of subjects suffering from
DLBCL following Rituximab administration. Sustained proliferation and enabled replicative
immortality, both being general hallmarks of cancer[7] result in a high cellular density of the
malignancy, which is a consistent finding in PCNSL[8].
Diffusion-Weighted Imaging (DWI), a technique based on phase-defocusing and phase
refocusing gradients has been used to measure the motion of water molecules on the micro-
spcopic scale. Besides its importance in stroke imaging, DWI plays a growing role in the char-
acterization of brain tumors. Tumors with densely packed cells like astrocytoma, lymphoma
and medulloblastoma[9] reveal an increased DWI signal on high b-values images and low
ADC values due to the relative restriction of water caused by high cellularity in combination
with high nuclear-to-cytoplasmic (N/C) ratios. The relation between low ADC values, high cel-
lularity and poor outcome has already been shown for PCNSL[10]. However, not all studies in
the field demonstrate an association between cellularity and ADC-values: Wu et al.[11] did not
find a correlation between ADC values and cellularity in Diffuse Large B-Cell Lymphoma and
Follicular Lymphoma. Although the relation between N/C ratio, cellularity and ADC values
has been examined in PCNSL, the association between water diffusibility (ADCmin, ADCmax,
ADCmean), proliferation rate (Ki-67 expression), total nuclear area, average nuclear area and
cell count has not yet been elucidated.
The purpose of this study was i) to investigate if ADC values in PCNSL correlate with
proliferative activity in terms of Ki-67 expression and ii) to further elucidate if ADC values




All patients or caregivers gave their informed consent for the asservation of sample remnants
and compiling of clinical and radiological data. Informed consent was given in writing. The
study was approved by the local ethics committee (Ethikkommission Universität Leipzig, Az
330-13-18112013).
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Potential patients in the period of January 2006 through March 2015 were identified on the
basis of the diagnosis PCNSL conducting a full-text search in the database of the institutes
for pathology and radiology, respectively. The search revealed 40 patients in the radiological
database, all of which were biopsied in our hospital and had a consecutive histopathological
workup. Only previously untreated patients with pretreatment DWI were included. None of
the studied patients were immunodeficient. Due to a lack of comparability of DWI measure-
ments between different MR scanners (Philips Intera, Philips Achieva and Siemens Symphony,
all 1.5T) we excluded 19 patients from our analysis. 21 patients (9 female, 13 male; 28–89 years,
mean age 68,5 years) met the inclusion criteria.
MR Imaging
All images were obtained in the clinical routine workup by using a 1.5T MRI scanner (Siemens
Magnetom Symphony 1,5T) with the standard Siemens head coil (CP head array, model
#1P3146037). DWI was performed using a single-shot spin-echo (SE) echo planar sequence
with following parameters: Echo time(TE)/Repetition time(TR) = 6000/105 ms, 90° flip angle,
57 transverse sections, slice thickness = 5 mm, field of view (FOV) = 230 mm. Diffusion-sensi-
tizing gradients were applied sequentially in the x, y and z directions with b factors of 0 and
1000 s/mm2. ADCs were automatically calculated at the operating console of the MR scanner
and displayed as corresponding ADCmaps. Postcontrast T1-weighted 3D-gradient echo
sequence(GRE) imaging was obtained with following parameters: TR/TE = 2150/3.93 ms, flip
angle 15°, 1-mm section thickness and 230 mm FOV. A standard dose (0.1 mmol/kg body
weight) of gadoteric acid (Gd-DOTA, Dotarem; Laboratoire Guerbet, Aulnay-sous-Bois,
France) was injected intravenously. Routine anatomic precontrast T1/ T2_tirm_tra_dark_fluid
(TR/TE = 9000/114, slice thickness 5mm, flip angle 150°, 28 transverse sections) images were
also obtained.
MR Image Analsysis
All images were available in digital format. Image analysis was performed on a Siemens SIE-
NETMagicView 1000 console previous to stereotactic biopsy. The lesion in question was deter-
mined by the stereotactic neurosurgeon. After stereotactic biopsy postinterventional images
were compared with preoperative images to confirm that the analysed lesion corresponded to
the biopsied portion of the tumor. B0, B1000 and ADC maps were coregistered with the post-
contrast T1-weighted 3D-gradient echo sequence to improve visualization and correlation.
Subsequently the readers reviewed the coregistered B0, B1000 and ADC maps and drew a sin-
gle circular region of interest (ROI)within the enhancing part of the tumor corresponding to
the biopsied portion. ROI size was determined depending on the size of the post-biopsy lesion,
the lower limit being 0.2cm2, the upper limit 0.49cm2. Hemorrhage, cysts and necrosis were
avoided when drawing the ROIs. ADC min, max and mean were measured on the correspond-
ing maps. Additionally, deltaADC (deltaADC = ADCmax—ADCmin) was calculated for each
tumor. The used technique for measuring ADC values was chosen because of its robustness
and clinical feasibility.
Histopathological Analysis
In every case the diagnosis of cerebral lymphoma was confirmed by surgical biopsy.
Ki-67 antigen stained specimens (MIB-1 monoclonal antibody, DakoCytomation, Den-
mark) were re-analyzed in this study. All images were digitalized by using a research micro-
scope Jenalumar with camera Diagnostic instruments 4.2 (Jena, Germany). The tumor
proliferation index was estimated as following relation: number of specifically stained nuclei
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divided by all nuclei. The area showing the highest number of positive cell nuclei was selected
in each case.
Cell count was calculated as total number of nuclei per two high power fields (x400).
In addition, the histological samples were analyzed for estimation of total and average
nucleic areas by using ImageJ software 1.48v (NIHS) as described in previous reports [12].
Tumor cell nuclei were easily identified by their color intensities. Total and average nucleic
areas were automatically calculated in two high power fields (x400).
Statistical analysis
Statistical analysis and graphics creation were performed using SPSS version 22. Collected
data was evaluated by means of descriptive statistics. Spearman-Rho correlation coefficient
was used to analyze the association between ADC values and histological parameters. P-
values< 0.05 were taken to indicate statistical significance.
Results
DWI measurements and histopathological analysis
All investigated PCNSL were located supratentorially and showed close proximity to the lateral
ventricles. The size of the lesions ranged from 1.2cm to 7.8cm. 6 out of 21 patients had multifo-
cal supratentorial lesions. As described above only the stereotactically biopsied part of the
tumor was analysed with MRI.
Fig 1a exemplarily shows a representative T1 weighted spin echo image of a CNS lymphoma
after gadolinium administration. Fig 1b shows the corresponding ADC map.
Table 1 displays gender, age and ADC fractions. Table 2 summarizes ADC values, cell
count, Ki-67 expression, total nucei area and average nuclei area of all PCNSL patients.
In brief, the ranges of ADC values were as follows: ADCmin = 35.0–85.0 10−4 mm2s-1 (mean
value 62.95x10-4 mm2s-1), ADCmean = 71.31–157.00x10-4 mm2s-1 (mean value 97.82x10-4
mm2s-1), ADCmax = 107.00–224.00x10-4 mm2s-1 (mean value 147.66x10-4 mm2s-1) and del-
taADC = 50.00–139.00x10-4 mm2s-1 (mean value 86.10x10-4 mm2s-1). Most lesions exhibited
high proliferation rates ranging from 50% to 95% with a mean value of 76.19% Ki67 expressing
nuclei. Fig 1c exemplarily shows Ki-67 staining of a primary CNS lymphoma. The immunos-
tained section corresponds to the lymphoma shown in fig 1a and 1b.
Total nuclei area was ranging widely from 19988.01 to 216517.76 μm2 with a mean value of
106617.71 μm2.
Interestingly, average nuclei areas had a large range as well, varying from 53.20 to 267.91μm2
with a mean value of 86.52 μm2.
Fig 1d exemplarily shows the particles tool analysis image corresponding to the lymphoma
shown in fig 1a, 1b and 1c.
Correlation analysis
Table 3 summarizes the statistical analysis of the relation between histopathological parame-
ters and ADC fractions, displaying the following findings: i) ADCmin showed a statistically
significant correlation with Ki-67 expression (r = -0.454, p = 0.038). No correlations were
found for ADCmin with nuclei count (r = -0.127, p = 0.584), total nuclei area (r = -0.228,
p = 0.312) or average nuclei size (r = -0.173, p = 0.455). ii) ADCmean showed statistically
significant correlations with Ki-67 expression (r = -0.546, p = 0.010) and total nuclei area
(r = -0.500, p = 0.021). No correlations were found between ADCmean and nuclei count
(r = -0.340, p = 0.132) or average nuclei size (r = -0.289, p = 0.204). iii) ADCmax showed a
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statistically significant correlation with Ki-67 expression (r = -0.515, p = 0.017). No correla-
tions were found for ADCmax with nuclei count (r = -0.012, p = 0.960), total nuclei area
(r = -0.155, p = 0.501) or average nuclei area (r = -0.144, p = 0.534). DeltaADC showed no
statistically significant correlations with the investigated histopathological features (del-
taADC and nuclei count: r = -0.223, p = 0.332; deltaADC and total nuclei area: r = -0.310,
p = 0.172; deltaADC and average nuclei area: r = -0.212, p = 0.357), although a trend was
delineable for deltaADC and Ki-67 (r = -0.428, p = 0.053). Fig 2 displays scatterplots graphi-
cally demonstrating the statistically significant relationships between DWI fractions and his-
topathological parameters.
Fig 1. MRI and histopathological findings in a patient with diagnosed cerebral lymphoma. a. T1w image documenting a lesion
with marked homogenous enhancement. b. ADCmap. The ADCmin value of the lesion is 64x10-4mm2s-1, the ADCmean value of the
lesion is 80×10−4 mm2s-1 and the ADCmax value is 133×10−4 mm2s-1. c. Immunohistochemical stain (MIB-1 monoclonal antibody).
Ki 67-index = 50%. d. “Particles tool” analysis image (ImageJ converted MIB-1 image). Cell count (total number of nuclei in the
image), total nucleic area (total area of all nuclei in the image) and average nucleic area (total area of all nuclei in the image divided
by the number of nuclei in the image) were calculated via the particles tool in ImageJ. For the image shown in fig 1d the following
values were determined by the “Particles tool” analysis; cell count = 1424, total nucleic area = 105678.14 μm2 and average nucleic
area = 74.37 μm2.
doi:10.1371/journal.pone.0161386.g001
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Discussion
To the best of our knowledge the inverse correlation between different ADC fractions and pro-
liferative activity of PCNSL has not been elucidated yet.
The present study identified significant correlations between ADCmin, ADCmean and
ADCmax measurements and cellular Ki-67 expression in biopsied portions of PCNSL, thus
reflecting tumor biology in terms of proliferative activity. Furthermore, the study validated in
vivo measured, low ADCmean values as a surrogate for tumor portions with increased nuclei
area, reflecting increased cellularity.
The significance of DWI for evaluation of PCNSL and differentiation from other brain
lesions has grown considerably over the years. An early study by Cotton and colleagues investi-
gated 9 biopsy-proven cases of cerebral lymphoma and found that the lesions were hyperin-
tense in DWI with normal or decreased ADC values[13]. A later study by Zacharia and
Table 1. Summary of age, sex and ADC values (ADCmin, ADCmean, ADCmax and deltaADC) of each lesion corresponding to the respective indivi-
duummeasured as described above. ADCmin, ADCmean, ADCmax and deltaADCvalues displayed as × 10−4 mm2s-1.
Sex Age (years) ADCmin (10−4 mm2s-1) ADCmax (10−4 mm2s-1) ADCmean (10−4 mm2s-1) deltaADC (10−4 mm2s-1)
F 64 64 152 87 51
M 73 53 158 98 108
M 78 72 123 88 127
M 59 65 174 115 50
F 74 85 224 150 82
F 28 51 123 71 69
F 89 64 133 80 68
F 80 60 110 85 109
M 79 64 133 87 73
M 86 58 126 73 67
M 67 70 141 91 71
M 64 77 190 140 88
M 55 49 170 74 121
M 82 66 139 87 72
F 77 77 157 107 69
M 73 54 121 87 80
M 32 65 147 89 139
M 64 35 120 80 85
F 78 70 178 118 113
F 55 60 121 81 105
M 65 63 190 114 61
doi:10.1371/journal.pone.0161386.t001
Table 2. Synopsis of ADC Fractions and histopathological parameters.
N Minimum Maximum Average Value Standard Deviation
ADCmin (10−4 mm2s-1) 21 35.00 85.00 62.95 11.01
ADCmax (10−4 mm2s-1) 21 107.00 224.00 146.67 30.92
ADCmean (10−4 mm2s-1) 21 71.31 157.00 97.83 25.12
deltaADC (10−4 mm2s-1) 21 50.00 139.00 86.10 25.37
Nuclei count 21 319.00 1922.00 1288.62 366.69
Total nuclei area (μm2) 21 19988.01 216517.76 106617.71 44549.13
Average nuclei area (μm2) 21 53.20 267.91 86.52 46.41
doi:10.1371/journal.pone.0161386.t002
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coworkers found that restricted diffusion with decreased ADC values is a consistent finding of
PCNSL in immunocompetent patients prior treatment[8]. Haldorsen et al. discussed that DWI
provides a potentially valuable tool to distinguish between glioma, metastases and PCNSL
based on cellularity-related diffusion restriction[14]. Kickingereder and colleagues found that
Table 3. Identified correlations between diffusion and histopathological parameters, statistically significant findings (p<0.05) are displayed in
bold italics.
Parameter Cell count Ki-67 (%) Total Nuclei Area (μm2) Average Nuclei Area *μm2)
r = p = r = p = r = p = r = p =
ADCmin (10-4mm2s-1) -0.127 0.584 -0.454 0.038 -0.228 0.321 -0.173 0.455
ADCmean (10-4mm2s-1) -0.340 0.132 - 0.546 0.010 -0.500 0.021 -0.289 0.204
ADCmax (10-4mm2s-1) 0.012 0.960 -0.515 0.017 -0.155 0.501 -.0144 0.534
deltaADC (104mm2s-1) -0.223 0.332 -0.428 0.053 -0.310 0.172 -0.212 0.357
doi:10.1371/journal.pone.0161386.t003
Fig 2. Significant correlations between ADC fractions (displayed as 10−4 mm2s-1) and histopathological parameters (Ki-67:
positively stained nuclei displayed in % and total nuclei area: displayed in μm2). Statistical analysis documenting significant
correlations between ADCmin and Ki-67 level (r = -0.454; p = 0.038) (a), ADCmean and Ki-67 level (r = -0.546; p = 0.010) (b), ADCmax and
Ki-67 level (r = -0.515; p = 0.017). Significant correlations between ADCmean and total nuclei area (r = -0.500; p = 0.021) (d) are also shown.
doi:10.1371/journal.pone.0161386.g002
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all ADC fractions (min, max and mean) were lower in PCNSL compared to glioblastoma[15].
Mabray and coworkers demonstrated that the combined use of ADC and CSF biomarkers
(CXC chemokine ligand 13 and interleukin 10) increased the diagnostic performance for the
diagnosis of PCNSL [16].
Although diffusion restriction is a consistent imaging finding in lymphoma, the question
whether in vivo measured ADC values reflect cellularity in lymphoma has been answered dif-
ferently in previous studies. For example, Wu and colleagues[9,11,17] showed that follicular
lymphoma and diffuse large B-cell lymphoma did not exhibit statistically different ADC values,
whereas the corresponding histopathological investigation revealed that the cellularity of both
entities varied greatly in a statistically significant manner. Contrary to this, Guo et al.[9]
showed that cellularity and ADC values correlated inversely in a statistically significant manner
after investigation of high grade astrocytomas and PCNSL.
The results of our study concur with the findings of Guo and colleagues, validating the link
between decreased water diffusibility in lymphomas measurable in MRI based on high cellular-
ity in histology. Values of ADC fractions in our study are approximately ten times larger than
those given by Guo et al.[9] and Cotton et al.[13]. We attribute this difference to the fact that
different MRI scanners and coils were used in these studies. Guo and colleagues used a 1.5T
GE platform, Cotton and colleagues used a 1.5T Philips MRI scanner and we used a 1.5T Sie-
mens scanner. As shown by Sasaki et al.[18] and Kivrak et al.[19], absolute ADC values can
substantially vary among different coil systems, imagers, vendors, and magnetic field strengths.
Although numerous studies provide evidence for the relationship of low ADC values and
high cellularity, the question which ADC parameter—ADCmin, ADCmean or ADCmax best
reflects the actual cellular density in a malignant tumor has not been answered conclusively.
Chen and coworkers[17,20] conducted a meta analysis investigating the relationship between
DWI and cellularity in different types of malignant tumors and found a strong, inverse correla-
tion between ADC and cellularity especially in brain tumors including PCNSL. According to
Chen et al. an overall of 14 studies examined the correlation of cellularity and restricted water
diffusibility in brain tumors. Three of these studies showed that ADCmin only reflected
increased cellularity. Ten out of fourteen studies showed that ADCmean only reflected
increased cellularity. Only one study showed that both, ADCmin and ADCmean indicated
high tumor cellularity. The fact that in few studies ADCmin alone reflected high cellularity,
whereas in the majority of the studies ADCmean (but not ADCmin) indicated high cellularity
raises the question as to how this discrepancy can be explained. Some studies did not reveal the
exact method for ADCmeasurement, generally ADC values were measured based on ROIs cor-
responding to the whole contrast agent enhancing part of the malignancy. These values were
correlated to the histologically derived data (e.g. cell count, nucleus-cytoplasm-ratio), which
represented only the very small, biopsied portion of the tumor. Since most of the malignant
tumors are composed of more aggressively infiltrating, rapidly dividing portions exhibiting
high cellularity and less biologically active portions, potentially hemorrhage and necrosis as
well, it is of great importance to only correlate the local apparent diffusion coefficient that cor-
responds to the biopsied, histologically examined part of the malignancy. As a consequence of
the aforementioned we assume that the varying correlations being found between ADCmin
and cellularity or ADCmean and cellularity, respectively, express differences in tumor hetero-
geneity between the different studies. Since we assume that ROIs, which extend to the whole
contrast agent enhancing part of the tumor (including significantly more than the histologi-
cally investigated part) may result in rather unspecific ADC measurements, we identified the
biopsied part of each PCNSL, measured the corresponding ADCmin, ADCmean and ADCmax
values and correlated them with nuclei count, total nuclei area and average nuclei area. We
found a conclusive, statistically significant correlation of ADCmean and total nuclei area,
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which concurs with the majority of the studies investigated by Chen and colleagues, indicating
ADCmean as a good in vivo measurable surrogate for increased cellularity.
In the second step this study revealed that ADCmin, ADCmean and ADCmax exhibit statis-
tically significant inverse correlations with Ki-67 expression, thus providing evidence of low
ADC values as in vivo surrogates for increased proliferative activity of PCNSL. This is in accor-
dance with the work of Guzmán-De-Villoria et colleagues[21], who found a trend of correla-
tion between low ADCmean values and Ki-67expression in glioma and other brain tumors. We
assume that the relationship between ADC values and Ki-67 expression in gliomas is more dif-
ficult to prove, since the tissue architecture of glioma is more heterogeneous and the resulting
ADC values exhibit a greater degree of variation compared to PCNSL. Other investigators were
able to determine that increasing ADC values indicate positive therapeutic responses of tumors
to antiproliferative treatment[22]. Further studies were able to show that low ADC values were
good indicators for the efficacy of specific, proliferation-inhibitory drugs[23,24]. With refer-
ence to our findings we hypothesize that the antiproliferative effect of chemotherapeutic drugs
results in a decrease of Ki-67 positive, proliferating cells and finally in a reduction of overall
tumor cellularity—thus leading to a measurable increase of water diffusibility in MRI. This
assumption is based on the results of Ho et al.[25] who were able to demonstrate that tumor
areas with low ADC values exhibit increased glucose-uptake, thus being more metabolically
active.
As reported by Surov et al., different histopathological features are associated with different
DWI parameters in meningioma[12]. Based on these findings and the results of our present
study we hypothesize that—due to the comparatively homogeneous cellular architecture of
CNS lymphoma—all ADC parameters in CNS lymphoma are influenced by the proliferative
activity of the tumor. In a recently published study we were able to show that expression of the
water channel Aquaporin 4 in meningioma correlates well with ADCmax values[26] We there-
upon assume that in different entities (lymphoma, meningioma, glioma etc.), diverse histo-
pathological and cyto-architectural features influence ADC parameters to a varying degree.
Our study had several limitations. The main limitation of our study is the use of perfusion-
sensitive ADC values. In the standardized clinical setting, DWI of the brain is conventionally
performed with a low (b = 0mm2/s) and a high b-value (b = 1000mm2/s). Diffusion-weighted
data acquired over a range of b values that includes low b values (< 100–150 s/mm2) are sensi-
tive to signal attenuation from capillary perfusion[27]. Perfusion-insensitive diffusion weighted
data can be obtained by using only higher b-values (>150 mm2/s)[27]. As shown by Priola
et al., the use of perfusion-insensitive ADC measurements significantly improves diagnostic
accuracy of DW-MRI[28]. Based on the fact that contrast enhancement was used as reference
for ROI positioning, the ADC values obtained in our study may be overestimated due to perfu-
sion effects[29,30]. Furthermore, the results of our study were possibly influenced by the small
sample size and the retrospective design. Additionally, only a small portion of the contrast
enhancing part of the mass was biopsied and investigated histopathologically, which does not
reflect probable tumor heterogeneity. The applied technique for measuring ADC values was
chosen because of its robustness and clinical feasibility.
Conclusion
This is the first study to show that ADCmin, ADCmean and ADCmax values are associated
with high proliferation rates of PCNSL, which indicates a promising potential for ADC mea-
surements as in vivo markers for treatment response or disease relapse. Furthermore, this
study confirmed ADCmean as best in vivo surrogate of DWI for cellular density in PCNSL.
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